Non-profit organisations provide an alternative to rescue stalled orphan drugs for biotechs struggling against a lethargic ...

Use of GLP-1RA therapies in CV/CKD disease with T2D will likely rise as physicians view them as addressers of cardiometabolic ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

Ensuring the highest standards in pharmaceutical logistics is crucial for patient safety and treatment efficacy.

The Weill Cancer Hub East has been established to explore the “interplay” between nutrition and immunotherapy in cancer ...

A total of 29 new blockbuster-in-waiting drugs entered the late-stage pipeline in 2024, a jump from the previous year’s 19.

Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity ...

EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.

MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease ...

Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.

The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and ...

Tribune has secured $39.9m in seed and Series A funding for its therapy portfolio aimed at the central drivers of scar tissue ...